Brief: Advicenne Completes First Round Of UK Pricing Negotiations For Sibnayal, Signs Two Exclusive Distribution Agreements in EU

Advicenne SA

07/12/2021 06:14

Dec 7 (Reuters) - Advicenne SA  ADVIC.PA :
    * ADVICENNE ANNOUNCES SIGNIFICANT PROGRESS IN MARKETING ITS
LEAD
PRODUCT SIBNAYAL™ IN EUROPE
    * FIRST ROUND OF PRICING NEGOTIATIONS COMPLETED IN UNITED
KINGDOM
    * TWINPHARMA AND EXCEED ORPHAN TO COMMERCIALIZE SIBNAYAL IN
BENELUX AND CENTRAL AND EASTERN EUROPEAN COUNTRIES RESPECTIVELY,
COVERING 25% OF ALL PATIENTS AFFECTED BY DRTA
    * WILL RECEIVE A COMBINATION OF TRANSFER PRICE AND ROYALTIES
FOR
AN AMOUNT MARKEDLY HIGHER THAN 50% OF FUTURE SALES OF SIBNAYAL

Source text for Eikon:  ID:nBw9xhNDna 
Further company coverage:  ADVIC.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))